Close Menu

NEW YORK (GenomeWeb News) – Oxford Nanopore Technologies plans to launch an early-access program for its MinIon sequencer in late November, the company said today.

Under the MinIon Access Program, an undisclosed but "substantial" number of selected participants will receive a MinIon system – consisting of the sequencing USB device, flow cells, and software – for a refundable deposit of $1,000 and shipping costs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.